Navigation Links
Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Date:10/10/2008

extensive randomized, controlled clinical trial program, with follow-up to five years in some cases. These trial results have been supplemented by data on more than 35,000 patients enrolled in post-approval registries. To date, approximately 4.6 million TAXUS stents have been implanted globally, making them the world's most frequently used drug-eluting stents.

The TAXUS Express2 stent (not the newer TAXUS Liberte stent) was used as the control against the Xience(TM) V Everolimus-Eluting Coronary Stent System in the SPIRIT II and III trials. XIENCE is a trademark of the Abbott Laboratories group of companies.

The TAXUS Liberte Stent is not available for sale in Japan, where it is undergoing regulatory review.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding regulatory approvals, clinical trials, product performance and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography
2. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
3. Video: Fortune 1000 Executives: New President Must Fix Education Gap
4. Video: Keppra XR(TM) Approved in the U.S.
5. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
6. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
7. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
8. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
9. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
10. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
11. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (PRWEB) August 21, 2014 His Majesty ... Opening , The Court of His Majesty Willem-Alexander, King ... attend the Grand Opening of POET-DSM Advanced Biofuels’ Project ... Sept. 3. , The King will take part in ... activity, scheduled for 11 a.m.-12:20 p.m. and tour the ...
(Date:8/21/2014)... , Aug. 21, 2014  Decision Resources Group ... Brazil and Mexico ... of several newly approved agents, the anticipated label ... and the launch of emerging biologics will substantially ... particular, the emerging IL-5 inhibitors will introduce a ...
(Date:8/21/2014)... , Aug. 21, 2014  China Cord Blood Corporation ... its plan to release financial results for the first ... 2014, after market close in the US.  ... 8:00 a.m. ET on Friday, August 29, 2014 to ... of the Company,s recent developments, followed by a question ...
(Date:8/21/2014)... August 21, 2014 Ontotext S4 ... by Ontotext . Now the same enterprise ... of structured and unstructured data is available to start-ups ... of enterprise technology. Organizations that do not have resources ... management can use S4 since there is no need ...
Breaking Biology Technology:His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... NEW YORK , May 28 ... an international biopharmaceutical company,with operations in the U.S. and China , ... , BSN, RN, HP (ASCP), has been,selected to present at the American ... . , , , ...
... A research ... gene transfer from host to parasite plant species. The discovery, reported in Science this week, ... ... A research team at RIKEN, Japan’s flagship research organization, has uncovered the first ever evidence ...
... May 27 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE,Amex: ... operations in the U.S. and China , announced that ... technologies at the Stem Cell,Investor & Executive Networking Conference Event ... 2010 . SCIENCE is designed to bring together investors with ...
Cached Biology Technology:NeoStem Selected to Present at American Society for Apheresis 2NeoStem Selected to Present at American Society for Apheresis 3NeoStem Selected to Present at American Society for Apheresis 4Parasite plants rob genes from their hosts 2NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 2NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 3NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 4NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 5
(Date:8/21/2014)... Nine researchers from Beth Israel Deaconess Medical Center ... "The World,s Most Influential Scientific Minds 2014," a ... ScienceWatch, a web resource for science metrics and research ... among the most influential "are performing and publishing work ... of their science," according to a Thomson Reuters statement. ...
(Date:8/21/2014)... in the journal Carcinogenesis by researchers at ... the protein adenomatous polyposis coli (APC) in suppressing colorectal ... the U.S. , Lead author Kristi Neufeld, associate professor ... the Cancer Biology program at the KU Cancer Center, ... to understand the various activities of APC, a protein ...
(Date:8/21/2014)... Acute pancreatitis involves the pancreas digesting itself resulting in ... in the UK around 20,000 patients are diagnosed with ... immediate cure and treatment is restricted to intravenous fluid ... the Faculty of Life Sciences, who led the research, ... reflux from gall stones and excessive alcohol intake combined ...
Breaking Biology News(10 mins):BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Insulin offers new hope for the treatment of acute pancreatitis 2
... Scientists at The University of Nottingham and the Wellcome Trust ... that control the three key stages in the life cycle ... third of these switches can be disrupted in some way. ... and the Medical Research Council (MRC) is a significant breakthrough ...
... journal, Science Translational Medicine , examines the structures ... commentary has been written by researchers from the National ... (BRC) at Guy,s and St Thomas, and King,s College ... Government and charitable investment in translational research taking place ...
... Health Sciences Center New Orleans has been awarded $12 ... Health to conduct research on diseases like prostate and ... herpes infections, as well as to support the development ... round of funding for a $10.6 million Center of ...
Cached Biology News:Malaria research begins to bite 2Malaria research begins to bite 3Strategies for translational research in the UK 2LSUHSC awarded $12 million for cancer, infectious diseases research & research pipeline 2LSUHSC awarded $12 million for cancer, infectious diseases research & research pipeline 3
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN...
2,4,6-Trinitrophenyl hapten is conjugated to Bovine Serum Albumin protein through lysine by amide bonds....
EoProbe Eosinophil Staining Kit, 1 Kit...
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
Biology Products: